Beam Therapeutics: Jefferies raises target price to $49 from $41
BEAM•Jefferies raised its target price for Beam Therapeutics to $49 from $41.
Related News
Blackstone closes fourth European direct lending fund
BX•
Sonic Automotive: Barclays cuts target price to $73 from $75
SAH•
Dollar retreats as Democratic wins in US midterms stoke AI regulation jitters
SPY•
Bank Handlowy third-quarter net profit reportedly expected to fall 41% year over year
C•
U.S. bonds rally as Democratic sweep seen stalling spending
TLT•